Cargando…

Duration biased distribution of clinical and immunological phenotypes in active SLE

INTRODUCTION: This study is aimed to map the clinical and immunological features of active lupus patients with different disease duration. METHODS: For clinical phenotype analysis, we enriched eligible medical records with active SLE (SLEDAI-2k≥8) from the Renji Lupus registry, a single-center datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Qingran, Liu, Bei, Yang, Minjie, Li, Qianqian, Wang, Jieying, Li, Ting, Lu, Liangjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794596/ https://www.ncbi.nlm.nih.gov/pubmed/36591231 http://dx.doi.org/10.3389/fimmu.2022.1044184

Ejemplares similares

Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer
por: Yan, Qingran, et al.
Publicado: (2023)

MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654
por: Tu, Yang, et al.
Publicado: (2019)

Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
por: García-Abellán, Javier, et al.
Publicado: (2022)

Characterization of cxorf21 Provides Molecular Insight Into Female-Bias Immune Response in SLE Pathogenesis
por: Harris, Valerie M., et al.
Publicado: (2019)

Sex-biased immunological processes drive hidradenitis suppurativa
por: Young, Kelly Z., et al.
Publicado: (2023)

Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome
por: Li, Qianqian, et al.
Publicado: (2022)

Deficient leptin receptor signaling in T cells of human SLE
por: Liu, Ting, et al.
Publicado: (2023)

Editorial: Mechanisms by Which SLE-Associated Genetic Variants Contribute to SLE Pathogenesis
por: Crispín, José C., et al.
Publicado: (2019)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

Assessing the Function of the ZFP90 Variant rs1170426 in SLE and the Association Between SLE Drug Target and Susceptibility Genes
por: Zhu, Tingting, et al.
Publicado: (2021)

Corrigendum: Assessing the Function of the ZFP90 Variant rs1170426 in SLE and the Association Between SLE Drug Target and Susceptibility Genes
por: Zhu, Tingting, et al.
Publicado: (2022)

Defects in Germinal Center Selection in SLE
por: Woods, Megan, et al.
Publicado: (2015)

SLE: Novel Postulates for Therapeutic Options
por: Hosszu, Kinga K., et al.
Publicado: (2020)

IFN-γ, should not be ignored in SLE
por: Liu, Wenping, et al.
Publicado: (2022)

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
por: Ko, Kichul, et al.
Publicado: (2013)

The immunological personality of close relatives of SLE patients
por: Salaman, M R, et al.
Publicado: (2017)

The First Case Report of Preschool-Onset SS/SLE Coexisting With NMOSD of Chinese Origin
por: Liu, Liqun, et al.
Publicado: (2022)

IFNα Inducible Models of Murine SLE
por: Liu, Zheng, et al.
Publicado: (2013)

Clinical and immunological characteristics of five patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China–expanding the atypical phenotypes
por: Huang, Yu, et al.
Publicado: (2022)

Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus
por: Liu, Yu, et al.
Publicado: (2021)

Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
por: Klemann, Christian, et al.
Publicado: (2019)

Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors
por: Bruns, Luzia, et al.
Publicado: (2022)

Estrogen Receptor Alpha Signaling Is Responsible for the Female Sex Bias in the Loss of Tolerance and Immune Cell Activation Induced by the Lupus Susceptibility Locus Sle1b
por: Graham, Jared H., et al.
Publicado: (2020)

A Novel Gene CDC27 Causes SLE and Is Associated With the Disease Activity
por: Shang, Shunlai, et al.
Publicado: (2022)

SLE: Another Autoimmune Disorder Influenced by Microbes and Diet?
por: Mu, Qinghui, et al.
Publicado: (2015)

Ex-TFRs: A Missing Piece of the SLE Puzzle?
por: Wei, Xundong, et al.
Publicado: (2021)

Interferon Genes Are Influenced by 17β-Estradiol in SLE
por: Singh, Ram P., et al.
Publicado: (2021)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

Characterization of the Immunologic Phenotype of Dendritic Cells Infected With Herpes Simplex Virus 1
por: Zhang, Jingjing, et al.
Publicado: (2022)

A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies
por: Laurynenka, Viktoryia, et al.
Publicado: (2022)

PRDX6AS1 gene polymorphisms and SLE susceptibility in Chinese populations
por: Zhang, Xiao-Xue, et al.
Publicado: (2022)

A Novel Serum tsRNA for Diagnosis and Prediction of Nephritis in SLE
por: Yang, Ping, et al.
Publicado: (2021)

An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
por: Yang, Kai, et al.
Publicado: (2018)

Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
por: Soni, Chetna, et al.
Publicado: (2019)

The effect of prolactin on immune cell subsets involved in SLE pathogenesis
por: Legorreta-Haquet, Maria Victoria, et al.
Publicado: (2022)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Identification of molecular subtypes based on liquid–liquid phase separation and cross-talk with immunological phenotype in bladder cancer
por: Sun, Le, et al.
Publicado: (2022)

Fine Mapping Analysis of the MHC Region to Identify Variants Associated With Chinese Vitiligo and SLE and Association Across These Diseases
por: Cao, Lu, et al.
Publicado: (2022)

Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE
por: Mahajan, Aparna, et al.
Publicado: (2016)

Oxidative Stress in SLE T Cells, Is NRF2 Really the Target to Treat?
por: Ohl, Kim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubuie91nlplu8o05448rara7ji